Structural basis of antizyme-mediated regulation of polyamine homeostasis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 36, 2015, Pages 11229-11234

  Wu, Hsiang Yi ^a   Chen, Shin Fu ^a   Hsieh, Ju Yi ^b   Chou, Fang ^a   Wang, Yu Hsuan ^b   Lin, Wan Ting ^a,b   Lee, Pei Ying ^a,b   Yu, Yu Jen ^a   Lin, Li Ying ^a,b   Lin, Te Sheng ^a,b   Lin, Chieh Liang ^a   Liu, Guang Yaw ^c,d   Tzeng, Shiou Ru ^a   Hung, Hui Chih ^b   Chan, Nei Li ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIZYME; ANTIZYME ISOFORM 1; HETERODIMER; HOMODIMER; ORNITHINE DECARBOXYLASE; POLYAMINE; PROTEASOME; UBIQUITIN; UNCLASSIFIED DRUG; ATP DEPENDENT 26S PROTEASE; AZIN1 PROTEIN, HUMAN; CARRIER PROTEIN; ENZYME INHIBITOR; PROTEIN; PROTEIN BINDING;

ARTICLE; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DIMERIZATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME SUBSTRATE; FUNCTIONAL ASSESSMENT; HOMEOSTASIS AND REGULATION; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; POLYAMINE METABOLISM; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; STRUCTURE ANALYSIS; SURFACE PROPERTY; AMINO ACID SEQUENCE; BIOCATALYSIS; CHEMISTRY; HOMEOSTASIS; HUMAN; KINETICS; METABOLISM; MOLECULAR GENETICS; MOLECULAR MODEL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SEQUENCE HOMOLOGY; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; BIOCATALYSIS; CARRIER PROTEINS; CRYSTALLOGRAPHY, X-RAY; ENZYME INHIBITORS; HOMEOSTASIS; HUMANS; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ORNITHINE DECARBOXYLASE; POLYAMINES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEINS; PROTEOLYSIS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84941309133     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1508187112     Document Type: Article

References (35)

1. Suzuki H, Kusano T. (2015) Polyamines: A Universal Molecular Nexus for Growth, Survival, and Specialized Metabolism (Springer, Japan).
2. Coffino P (2001) Regulation of cellular polyamines by antizyme. Nat Rev Mol Cell Biol 2(3):188-194.
3. Pegg AE (2006) Regulation of ornithine decarboxylase. J Biol Chem 281(21):14529-14532.
4. Casero RA, Jr, Marton LJ (2007) Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov 6(5):373-390.
5. Olsen RR, Zetter B.R. (2011) Evidence of a role for antizyme and antizyme inhibitor as regulators of human cancer. Mol Cancer Res 9(10):1285-1293.
6. Kahana C (2009) Antizyme and antizyme inhibitor, a regulatory tango. Cell Mol Life Sci 66(15):2479-2488.
7. Matsufuji S, et al (1995) Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell 80(1):51-60.
8. Rom E, Kahana C. (1994) Polyamines regulate the expression of ornithine decarboxylase antizyme in vitro by inducing ribosomal frame-shifting. Proc Natl Acad Sci USA 91(9): 3959-3963.
9. Kurian L, Palanimurugan R, Gödderz D, Dohmen R.J. (2011) Polyamine sensing by nascent ornithine decarboxylase antizyme stimulates decoding of its mRNA. Nature 477 (7365):490-494.
10. Fujita K, Matsufuji S, Murakami Y., Hayashi S. (1984) Antizyme to ornithine decarboxylase is present in the liver of starved rats. Biochem J 218(2):557-562.
11. Murakami Y, et al (1992) Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature 360 (6404):597-599.
12. Ivanov IP, Gesteland RF, Atkins J.F. (1998) A second mammalian antizyme: Conservation of programmed ribosomal frameshifting. Genomics 52(2):119-129.
13. Ivanov IP, Rohrwasser A, Terreros D.A., Gesteland RF, Atkins J.F. (2000) Discovery of a spermatogenesis stage-specific ornithine decarboxylase antizyme: antizyme 3. Proc Natl Acad Sci USA 97(9):4808-4813.
14. Murakami Y, Ichiba T, Matsufuji S., Hayashi S. (1996) Cloning of antizyme inhibitor, a highly homologous protein to ornithine decarboxylase. J Biol Chem 271(7): 3340-3342.
15. Auvinen M, Paasinen A, Andersson L.C., Hölttä E (1992) Ornithine decarboxylase activity is critical for cell transformation. Nature 360 (6402):355-358.
16. Iwata S, et al (1999) Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation. Oncogene 18(1): 165-172.
17. Hsieh JY, Yang JY, Lin C.L., Liu GY, Hung H.C. (2011) Minimal antizyme peptide fully functioning in the binding and inhibition of ornithine decarboxylase and antizyme inhibitor. PLoS One 6(9):e24366.
18. Almrud JJ, et al (2000) Crystal structure of human ornithine decarboxylase at 2.1 A resolution: Structural insights to antizyme binding. J Mol Biol 295(1):7-16.
19. Li X, Coffino P. (1993) Degradation of ornithine decarboxylase: Exposure of the C-terminal target by a polyamine-inducible inhibitory protein. Mol Cell Biol 13(4): 2377-2383.
20. Hoffman DW, Carroll D, Martinez N., Hackert M.L. (2005) Solution structure of a conserved domain of antizyme: A protein regulator of polyamines. Biochemistry 44(35): 11777-11785.
21. Chen H, MacDonald A, Coffino P. (2002) Structural elements of antizymes 1 and 2 are required for proteasomal degradation of ornithine decarboxylase. J Biol Chem 277(48):45957-45961.
22. Zhang M, Pickart CM, Coffino P. (2003) Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate. EMBO J 22(7): 1488-1496.
23. Prakash S, Tian L, Ratliff K.S., Lehotzky RE, Matouschek A. (2004) An unstructured initiation site is required for efficient proteasome-mediated degradation. Nat Struct Mol Biol 11(9):830-837.
24. Berko D, et al (2012) The direction of protein entry into the proteasome determines the variety of products and depends on the force needed to unfold its two termini. Mol Cell 48(4):601-611.
25. Snapir Z, Keren-Paz A, Bercovich Z., Kahana C. (2009) Antizyme 3 inhibits polyamine uptake and ornithine decarboxylase (ODC) activity, but does not stimulate ODC degradation. Biochem J 419(1):99-103.
26. Albeck S, et al (2008) Crystallographic and biochemical studies revealing the structural basis for antizyme inhibitor function. Protein Sci 17(5):793-802.
27. Chen L, et al (2013) Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med 19(2):209-216.
28. Kim W, et al (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44(2):325-340.
29. Adams PD, et al (2010) PHENIX: A comprehensive Python-based system for macro-molecular structure solution. Acta Crystallogr D Biol Crystallogr 66(Pt 2):213-221.
30. Dam J, Schuck P. (2005) Sedimentation velocity analysis of heterogeneous proteinprotein interactions: Sedimentation coefficient distributions c(s) and asymptotic boundary profiles from Gilbert-Jenkins theory. Biophys J 89(1):651-666.
31. Minor W, Cymborowski M, Otwinowski Z., Chruszcz M. (2006) HKL-3000: The integration of data reduction and structure solution-From diffraction images to an initial model in minutes. Acta Crystallogr D Biol Crystallogr 62(Pt 8):859-866.
32. Emsley P, Cowtan K. (2004) Coot: Model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60(Pt 12 Pt 1):2126-2132.
33. Kahana C (2011) Identification, assay, and functional analysis of the antizyme inhibitor family. Methods Mol Biol 720:269-278.
34. Schuck P, Perugini MA, Gonzales N.R., Howlett GJ, Schubert D. (2002) Size-distribution analysis of proteins by analytical ultracentrifugation: Strategies and application to model systems. Biophys J 82(2):1096-1111.
35. Laue TM, Shah BD, Ridgeway T.M., Pelletier S.L. (1992) Analytical Ultracentrifugation in Biochemistry and Polymer Science (The Royal Society of Chemistry, Cambridge, UK).